Clinical Trial Update: A Study of LY2189265 Compared to Sitagliptin in Participants With Type 2 Diabetes Mellitus on Metformin [Phase 2, Phase 3]

View source ↗

Summary

Clinical trial update reporting results from a Phase 2/Phase 3 study comparing LY2189265 to sitagliptin in adults with Type 2 diabetes mellitus on metformin, wi…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• LY2189265
• Sitagliptin (sitagliptin)

Snippet

Sponsor: Eli Lilly and Company | Conditions: Diabetes Mellitus, Type 2 | Phase 2, Phase 3 | Status: COMPLETED | Results posted: 2015-01-28